En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
17635.1 PFLS-LS
Titre du projet
Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5
Titre du projet anglais
Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
Anzeigen
-
-
Anzeigen
Résumé des résultats (Abstract)
Anzeigen
-
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Allemand)
Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5
Description succincte
(Anglais)
Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5
Résumé des résultats (Abstract)
(Allemand)
Clinical testing of two components for a synthetic peptide-based virosomal malaria vaccine has yielded promising results, encouraging the search for additional components for inclusion in a final multivalent vaccine formulation. This CTI project should support design, optimisation and final preclinical profiling of additional mimotopes derived from key vaccine conserved antigens for protection against different strains in an innovative P. falciparum infection mouse model.
Résumé des résultats (Abstract)
(Anglais)
Clinical testing of two components for a synthetic peptide-based virosomal malaria vaccine has yielded promising results, encouraging the search for additional components for inclusion in a final multivalent vaccine formulation. This CTI project should support design, optimisation and final preclinical profiling of additional mimotopes derived from key vaccine conserved antigens for protection against different strains in an innovative P. falciparum infection mouse model.